At the interim analysis, in asymptomatic mutation carriers, the hazard ratio for clinical decline in the Clinical Dementia Rating-Sum of Boxes was 0.79 for participants ... for people at risk for ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. That’s according to a new study from Washington University School of ...

He died of Alzheimer’s in 2019, at the age of 66. “That’s old for our family,” Reiswig said. For years, Reiswig resisted finding out whether he carried the mutation, but he did get tested ...

MINNEAPOLIS — While some studies have suggested that having a mother with Alzheimer’s disease may put you more at risk of developing the disease, a new study finds that having a father with ...

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green light to ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of ...